Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.
Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.
How COVID-19 Has Changed the Way We Approach Head & Neck Cancer Care
How COVID-19 Has Changed the Way We Approach Head & Neck Cancer Care
The COVID-19 Pandemic & Dangerous Delays in Cancer Screenings
The COVID-19 Pandemic & Dangerous Delays in Cancer Screenings
Higher Risk, Lowered Age: New Colorectal Cancer Screening Guidelines
Higher Risk, Lowered Age: New Colorectal Cancer Screening Guidelines
Not Quite a Cancer Vaccine: Selling HPV & Cervical Cancer
Not Quite a Cancer Vaccine: Selling HPV & Cervical Cancer
FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
Pancreatic Cancer: The Hunt to Catch a Silent Killer
Pancreatic Cancer: The Hunt to Catch a Silent Killer
FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer
FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer
FDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer
FDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer
Linking p53 Variation to Breast Cancer Risk in African American Women
Linking p53 Variation to Breast Cancer Risk in African American Women
FDA D.I.S.C.O.: First Tissue/Site Agnostic Cancer Treatment Approval
FDA D.I.S.C.O.: First Tissue/Site Agnostic Cancer Treatment Approval
Pancreatic Cancer: Associated Signs, Symptoms, Risk Factors and Treatment Approaches
Pancreatic Cancer: Associated Signs, Symptoms, Risk Factors and Treatment Approaches
FDA D.I.S.C.O.: Avelumab in Merkel Cell Carcinoma
FDA D.I.S.C.O.: Avelumab in Merkel Cell Carcinoma
FDA D.I.S.C.O.: Niraparib in Ovarian Cancer
FDA D.I.S.C.O.: Niraparib in Ovarian Cancer
Beyond the Colonoscopy: New Screening Guidelines for Colorectal Cancer
Beyond the Colonoscopy: New Screening Guidelines for Colorectal Cancer
High Hopes for Cannabis in Oncology: Therapeutic Applications Beyond Pain Management
High Hopes for Cannabis in Oncology: Therapeutic Applications Beyond Pain Management